The scientific production of the Renal Cancer Unit predominantly focuses on the following main topics:
- Renal Cell Carcinoma and other renal histologies. Over the past 10 years, the scientific activities were dedicated to the field of kidney cancer, in particular in the settings of Small Renal Masses (SMR), locally advanced and metastatic kidney cancer.
- Epidemiology, socio-demography, physiopathology, diagnosis, medical and surgical treatment of kidney cancer
- Imaging and diagnostic procedures for kidney cancer patients.
- Functional urology and surgery of renal cancer
Capitanio U, Montorsi F. Renal cancer. The Lancet. 2016 Feb 27;387(10021):894-906. doi: 10.1016/S0140-6736(15)00046-X.
Capitanio, U., et al. Kidney Cancer Working Group of the Young Academic Urologists Working Party of the European Association of Urology. Do We Truly Care About the Functional Outcomes for Renal Cancer Patients? Multidisciplinarity Is Still Far Away, 2019, European Urology, 75, pp. 349-350. DOI:10.1016/j.eururo.2018.08.040)
Capitanio U, et al. Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with a T1a-T1b renal mass and normal preoperative renal function. Eur Urol. 2015 Apr;67(4):683-9. doi: 10.1016/j.eururo.2014.09.027.
Capitanio U, et al. Hypertension and Cardiovascular Morbidity Following Surgery for Kidney Cancer. Eur Urol Oncol. 2019. doi: 10.1016/j.euo.2019.02.006.
Capitanio U, et al. Extent of lymph node dissection at nephrectomy affects cancer-specific survival and metastatic progression in specific sub-categories of patients with renal cell carcinoma (RCC). BJU Int. 2014 Aug;114(2):210-5. doi: 10.1111/bju.12508).